Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Background Ketamine has been reported to exert anti-inflammatory effects on macrophages stimulated with lipopolysaccharide (LPS) in vitro and in vivo. Several studies have reported conflicting results regarding the effects of propofol on cytokine production from immune cells. However, there have been no reports of the effects of these agents on inflammatory responses in glial cells. We investigated the effects of ketamine and propofol on LPS-induced production of nitric oxide, tumour necrosis factor-alpha (TNF-alpha) and prostaglandin E(2) (PGE(2)) from primary cultures of rat glial cells in vitro. Methods Glial cells were stimulated with LPS in the absence and presence of various concentrations of ketamine (30-1000 microM) or propofol (30 and 300 microM). Nitric oxide released into the culture media was determined by measuring nitrite using the Griess reaction, and concentrations of TNF-alpha and PGE(2) were measured by enzyme-linked immunosorbent assay (ELISA). Results Ketamine reduced LPS-induced TNF-alpha production without significant inhibition of nitrite release in mixed glial cells, astrocyte cultures and microglial cultures. Ketamine also inhibited LPS-induced production of PGE(2) in astrocyte cultures. In contrast, propofol had no effect on LPS-induced nitrite or TNF-alpha production in mixed glial cells. Conclusions The data demonstrate that ketamine inhibited some of the inflammatory responses of both astrocytes and microglial cells treated with LPS without causin…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a large amount of evidence suggests a tight relationship between neuroinflammation and the pathogenesis of MDD. 485 – 487”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [487]
Citations
Cites
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Cytokines and acute neurodegeneration
Allan, S. M., & Rothwell, N. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094583 · Cited by 1,123
Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., et al. (2001) · Nature Neuroscience · doi:10.1038/89490 · Cited by 1,102
MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES
González-Scarano, F., & Baltuch, G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.219 · Cited by 984
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics
Barone, F. C., & Feuerstein, G. Z. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199908000-00001 · Cited by 930
Bhat, N. R., Zhang, P., Lee, J. C., & Hogan, E. L. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01633.1998 · Cited by 713
Innate immunity: the missing link in neuroprotection and neurodegeneration?
Nguyen, M. D., Julien, J.-P., & Rivest, S. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn752 · Cited by 701
GLIA: A novel drug discovery target for clinical pain
Watkins, L. R., & Maier, S. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1251 · Cited by 672
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“377 – 487 A summary of clinical trials related to new therapeutic drugs for MDD is shown in Table 1.”
BackgroundInflammation, Glutamate, and Glia in Depression:A Literature Review
McNally, L., Bhagwagar, Z., & Hannestad, J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016734 · Cited by 289
Microglia in depression: current perspectives
Jia, X., Gao, Z., & Hu, H. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1815-6 · Cited by 282
“In addition, ketamine treatment sig- nificantly reduced LPS-induced production of TNF-α, NO and IL-1β in cultured microglia (Chang et al., 2009; Shibakawa et al., 2005).”
BackgroundThe cortical innate immune response increases local neuronal excitability leading to seizures
Rodgers, K. M., Hutchinson, M. R., Northcutt, A., Maier, S. F., Watkins, L. R., & Barth, D. S. (2009) · Brain · doi:10.1093/brain/awp177 · Cited by 162
“The purpose of this aneasthesia regime was to eliminate ketamine, which can influence epileptogenicity (Velisek et al., 1993; Borowicz and Czuczwar, 2003; Midzyanovskaya et al., 2004) and also attenuate LPS-induced inflammatory responses of glial cultures (Shibakawa et al., 2005).”
BackgroundNijs, J., Loggia, M. L., Polli, A., Moens, M., Huysmans, E., Goudman, L., Meeus, M., Vanderweeën, L., Ickmans, K., & Clauw, D. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1353603 · Cited by 141
“In vitro work showed that ketamine inhibited some of the inflammatory responses of both astrocytes and microglial cells [114].”
Background
Metadata
- Authors
- Shibakawa, Y. S., Sasaki, Y., Goshima, Y., Echigo, N., Kamiya, Y., Kurahashi, K., Yamada, Y., & Andoh, T.
- Affiliations
- Yokohama City University (JP)
- Corresponding author
- Andoh, T.
- Venue
- British Journal of Anaesthesia
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 95
- Issue
- 6
- Pages
- 803-810
- ISSN
- 0007-0912 (ISSN-L)
- OpenAlex
- W2122830024
- Cited by
- 96
- References
- 38
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 8 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 1 · 2015: 4 · 2014: 4 · 2013: 8 · 2012: 7
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4386 d)
- Locations
- British Journal of Anaesthesia (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Funders
- Fonden til Lægevidenskabens Fremme
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Anesthesia and Neurotoxicity Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- ketamine, propofol, glial cells, lipopolysaccharide, neuroinflammation, astrocytes, microglia, nitric oxide, TNF-α, prostaglandin E2, anti-inflammatory activity
- MeSH terms
- Anesthetics, Dissociative, Animals, Astrocytes, Cells, Cultured, Dose-Response Relationship, Drug, Ketamine, Lipopolysaccharides, Neuroglia, Nitric Oxide, Tumor Necrosis Factor-alpha, Dinoprostone, Propofol, Rats, Wistar, Microglia, Anesthetics, Intravenous, Inflammation Mediators, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide. https://app.cochat.ai/papers/10.1093/bja/aei256
- The paper
- Shibakawa, Y. S., Sasaki, Y., Goshima, Y., Echigo, N., Kamiya, Y., Kurahashi, K., Yamada, Y., & Andoh, T. (2005). Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide. British Journal of Anaesthesia. https://doi.org/10.1093/bja/aei256
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.